HOME › DRUGS › PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (20-VALENT, ADSORBED)
ACTIVE SUBSTANCE / INN

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (20-VALENT, ADSORBED)

Brand name(s): Prevenar 20 (previously Apexxnar)
EMA LISTED
AUTHORISED
Pneumococcal Infections
ACTIVE SUBSTANCE
Pneumococcal Polysaccharide Conjugate Vaccine (20-Valent, Adsorbed)
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Prevenar 20 (previously Apexxnar)Pfizer Europe MA EEIGAuthorised14/02/2022Pneumococcal Infections

FULL INTELLIGENCE ON PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (20-VALENT, ADSORBED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →